CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 143 filers reported holding CLOVIS ONCOLOGY INC in Q2 2014. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $18,634,000 | +4.6% | 202,630 | 0.0% | 0.17% | +10.3% |
| Q2 2015 | $17,807,000 | +18.4% | 202,630 | 0.0% | 0.16% | +24.8% |
| Q1 2015 | $15,041,000 | +32.6% | 202,630 | 0.0% | 0.12% | +7.8% |
| Q4 2014 | $11,347,000 | -65.5% | 202,630 | -74.5% | 0.12% | -71.1% |
| Q2 2014 | $32,847,000 | -10.5% | 793,221 | +49.7% | 0.40% | -13.9% |
| Q1 2014 | $36,712,000 | +14.8% | 529,990 | -0.1% | 0.47% | +3.5% |
| Q4 2013 | $31,988,000 | +74.4% | 530,738 | +75.9% | 0.45% | +72.8% |
| Q3 2013 | $18,346,000 | -47.8% | 301,744 | -42.5% | 0.26% | -62.5% |
| Q2 2013 | $35,172,000 | – | 525,113 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |